GlassScriptPhysician profile
Karan Sud
NPI 1164876652
$30,430.44
in general payments reported to CMS, 2019-2025
22 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.78 · 2021: $788 · 2022: $1,303 · 2023: $661 · 2024: $7,059 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $3,752 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,067 · Travel and Lodging: $1,558 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $19,759.29 |
| Food and Beverage | $3,751.74 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,066.78 |
| Travel and Lodging | $1,558.32 |
| Education | $162.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,249.91 | 2021-2025 | Hawkone, Onyx Frontier, Symplicity G3 |
| Abbott Laboratories | $5,398.40 | 2024-2025 | Xience V, Diamondback Coronary, Mitraclip |
| Edwards Lifesciences Corporation | $2,232.53 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,779.05 | 2021-2025 | Stingray, Watchman, Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $651.61 | 2021-2024 | Repatha |
| Shockwave Medical, INC | $531.20 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $357.15 | 2021-2022 | |
| Teleflex LLC | $314.15 | 2025 | Turnpike |
| Astrazeneca Pharmaceuticals LP | $182.02 | 2021-2024 | Farxiga |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Terumo Medical Corporation | $128.29 | 2022-2023 | Tr Band, Glidesheath Slender, Optitorque |
| Cardiovascular Systems INC. | $116.38 | 2021 | |
| Daiichi Sankyo INC. | $80.23 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $65.98 | 2023-2024 | Verquvo |
| Pfizer INC. | $40.78 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $32.21 | 2023 | Alphavac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.46 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $24.39 | 2022 | |
| Getinge USA Sales, LLC | $23.28 | 2023 | Cardiosave Hybrid, Type B Plug |
| Abiomed | $20.05 | 2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $18.31 | 2024 | |
| Philips North America LLC | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Sud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.